Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical

Mankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two insulin analogues for diabetes care. The deal will enhance Mankind Pharma's injectable diabetes segment offerings. These new products will strengthen the company's comprehensive patient portfolio.